| Bioactivity | Hel 13-5 is a monomeric synthetic peptide based on the N-terminal segment of human SP-B. Hel 13-5 mainly is a-helical and consists of 13 hydrophobic and 5 hydrophilic amino acid residues. Hel 13-5 can be used in combination with phospholipids for developing pulmonary surfactant model systems[1][2]. |
| Name | Hel 13-5 |
| CAS | 177942-21-1 |
| Sequence | Lys-Leu-Leu-Lys-Leu-Leu-Leu-Lys-Leu-Trp-Leu-Lys-Leu-Leu-Lys-Leu-Leu-Leu |
| Shortening | KLLKLLLKLWLKLLKLLL |
| Formula | C113H204N24O19 |
| Molar Mass | 2202.98 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nakahara H, et al. Pulmonary surfactant model systems catch the specific interaction of an amphiphilic peptide with anionic phospholipid. Biophys J. 2009 Feb 18;96(4):1415-29. [2]. Nakahara H, et al. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfacten (Surfactant TA). Langmuir. 2008 Apr 1;24(7):3370-9. |
Hel 13-5
CAS: 177942-21-1 F: C113H204N24O19 W: 2202.98
Hel 13-5 is a monomeric synthetic peptide based on the N-terminal segment of human SP-B. Hel 13-5 mainly is a-helical an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.